Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury

The advent of nanomedicine requires novel delivery vehicles to actively target their site of action. Here, we demonstrate the development of lung-targeting drug-loaded liposomes and their efficacy, specificity and safety. Our study focuses on glucocorticoids methylprednisolone (MPS), a commonly used...

Full description

Saved in:
Bibliographic Details
Main Authors: Nan Li (Author), Dong Weng (Author), Shan-Mei Wang (Author), Yuan Zhang (Author), Shan-Shan Chen (Author), Zhao-Fang Yin (Author), Jiali Zhai (Author), Judy Scoble (Author), Charlotte C. Williams (Author), Tao Chen (Author), Hui Qiu (Author), Qin Wu (Author), Meng-Meng Zhao (Author), Li-Qin Lu (Author), Xavier Mulet (Author), Hui-Ping Li (Author)
Format: Book
Published: Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_878c58768b05496aae6d02a1f77e2fcf
042 |a dc 
100 1 0 |a Nan Li  |e author 
700 1 0 |a Dong Weng  |e author 
700 1 0 |a Shan-Mei Wang  |e author 
700 1 0 |a Yuan Zhang  |e author 
700 1 0 |a Shan-Shan Chen  |e author 
700 1 0 |a Zhao-Fang Yin  |e author 
700 1 0 |a Jiali Zhai  |e author 
700 1 0 |a Judy Scoble  |e author 
700 1 0 |a Charlotte C. Williams  |e author 
700 1 0 |a Tao Chen  |e author 
700 1 0 |a Hui Qiu  |e author 
700 1 0 |a Qin Wu  |e author 
700 1 0 |a Meng-Meng Zhao  |e author 
700 1 0 |a Li-Qin Lu  |e author 
700 1 0 |a Xavier Mulet  |e author 
700 1 0 |a Hui-Ping Li  |e author 
245 0 0 |a Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury 
260 |b Taylor & Francis Group,   |c 2017-01-01T00:00:00Z. 
500 |a 1071-7544 
500 |a 1521-0464 
500 |a 10.1080/10717544.2017.1402217 
520 |a The advent of nanomedicine requires novel delivery vehicles to actively target their site of action. Here, we demonstrate the development of lung-targeting drug-loaded liposomes and their efficacy, specificity and safety. Our study focuses on glucocorticoids methylprednisolone (MPS), a commonly used drug to treat lung injuries. The steroidal molecule was loaded into functionalized nano-sterically stabilized unilamellar liposomes (NSSLs). Targeting functionality was performed through conjugation of surfactant protein A (SPANb) nanobodies to form MPS-NSSLs-SPANb. MPS-NSSLs-SPANb exhibited good size distribution, morphology, and encapsulation efficiency. Animal experiments demonstrated the high specificity of MPS-NSSLs-SPANb to the lung. Treatment with MPS-NSSLs-SPANb reduced the levels of TNF-α, IL-8, and TGF-β1 in rat bronchoalveolar lavage fluid and the expression of NK-κB in the lung tissues, thereby alleviating lung injuries and increasing rat survival. The nanobody functionalized nanoparticles demonstrate superior performance to treat lung injury when compared to that of antibody functionalized systems. 
546 |a EN 
690 |a acute lung injury 
690 |a bioconjugation 
690 |a liposomes; lung-targeted drug delivery 
690 |a surfactant protein-a 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drug Delivery, Vol 24, Iss 1, Pp 1770-1781 (2017) 
787 0 |n http://dx.doi.org/10.1080/10717544.2017.1402217 
787 0 |n https://doaj.org/toc/1071-7544 
787 0 |n https://doaj.org/toc/1521-0464 
856 4 1 |u https://doaj.org/article/878c58768b05496aae6d02a1f77e2fcf  |z Connect to this object online.